Chargement en cours...
Prophylactic Cranial Irradiation after Definitive Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: Do All Patients Benefit
PURPOSE: Prophylactic cranial irradiation (PCI) can improve overall survival (OS) and suppress brain metastases (BM) in patients with limited-stage small cell lung cancer (LS-SCLC) after complete response to primary therapy. However, PCI can be toxic. We sought to identify characteristics of patient...
Enregistré dans:
| Publié dans: | Radiother Oncol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319879/ https://ncbi.nlm.nih.gov/pubmed/28073578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2016.11.012 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|